A feature about Chandler Robinson, Gates scholar and MBA alumnus at Cambridge Judge Business School (MBA 2009). Chandler says his MBA studies helped him to start biotech company Monopar Therapeutics that is developing a drug to treat Wilson’s Disease. The drug is now in Phase III trials and has been recently acquired by Wilson Therapeutics for $855 million. “Never in my wildest dreams did I think that I could do an MBA and become CEO of a company,” Chandler said.
Read the full article [gatescambridge.org]